TrialAdvances in therapy2015

Decitabine for Treatment of Myelodysplastic Syndromes in Chinese Patients: An Open-Label, Phase-3b Study.

Depei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.